Overall rank by patents
#21,687
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 15 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
According to USPTO PatentsView, Restek ranks #21,687 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 15 technology areas.
USPTO PatentsView assignee plate
Corpus R21687 · US Corporation #21,687 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Refai Technologies, L.l.c. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Restek · this assignee
54 score
3D Lighting Innovati… · lowest
7 score
What this shows Restek's Innovation Score is 54.0/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Restek Corporation is a focused PatentsView assignee: 15 CPC subclasses with 76.9% of grants classified under G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2016. By volume, Restek sits between Refai Technologies, L.l.c. and Rf360 Europe Gmbh.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
REFAI TECHNOLOGIES, L.L.C.
13 patents
REISHAUER AG
13 patents
RENISHAW (IRELAND) LIMITED
13 patents
REPRIEVE CARDIOVASCULAR, INC.
13 patents
REVIVA PHARMACEUTICALS, INC.
13 patents
REVIVO MEDICAL, LLC
13 patents
REYCO GRANNING, LLC
13 patents
RF360 Europe GmbH
13 patents
RESTEK CORPORATION
13 patents
What this shows Restek holds 13 patents at rank #21,666, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #21,666 in granted patent volume.
Other assignees with the most granted patents in Restek's primary technology class.
Restek's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 7.7% |
| 2018 | 1 | 7.7% |
| 2021 | 1 | 7.7% |
| 2023 | 4 | 30.8% |
| 2024 | 4 | 30.8% |
| 2025partial year | 2 | 15.4% |
Top 15 of 15 technology areas
Overall rank by patents
#21,687
of 50,000 tracked assignees
54.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.